(1S,5S,6R,7R)-7-chloro-5-methyl-2-azabicyclo[4.1.0]heptan-3-thione | 1393682-16-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: (1S,5S,6R,7R)-7-chloro-5-methyl-2-azabicyclo[4.1.0]heptan-3-thione
• 英文别名: (1S,5S,6R,7R)-7-chloro-5-methyl-2-azabicyclo[4.1.0]heptane-3-thione
• CAS: 1393682-16-0
• 化学式: C₇H₁₀ClNS
• 分子量: 175.682
• InChiKey: NDTOYMDFMRFESL-OIADKPKDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  44.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (1S,5S,6R,7R)-7-chloro-5-methyl-2-azabicyclo[4.1.0]heptan-3-thione 在 氨 、 盐酸 作用下， 以 甲醇 为溶剂， 反应 46.0h， 以45%的产率得到ONO-1714
  参考文献：
  名称：

  New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714

  摘要：

  In an experimental permanent stroke model, we report here the contribution of ONO-1714 to brain damage prevention. Daily drug administration, twenty-one days prior to and two days after an experimental infarct, was performed by using mini-osmotic pumps (ALZET). Infarct volumes were assessed by image analysis of sequential corona] brain 1 mm(3) sections stained following the 2,3,5-triphenyltetrazolium chloride histological staining technique. Results of this study provide evidence of a significant reduction of the brain lesion size, suggesting ONO-1714 as a potential neuroprotective agent in stroke patients. ONO-1714 was prepared in our laboratory following a procedure which resulted in the supply of the desired compound in an easy and excellent yield. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.05.031
• 作为产物：
  描述：

  (1S,5S,6R,7S)-7-chloro-2-(2,4-dimethoxybenzyl)-5-methyl-2-azabicyclo[4.1.0]heptan-3-thione 在 三氟乙酸 作用下， 反应 16.0h， 以70%的产率得到(1S,5S,6R,7R)-7-chloro-5-methyl-2-azabicyclo[4.1.0]heptan-3-thione
  参考文献：
  名称：

  New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714

  摘要：

  In an experimental permanent stroke model, we report here the contribution of ONO-1714 to brain damage prevention. Daily drug administration, twenty-one days prior to and two days after an experimental infarct, was performed by using mini-osmotic pumps (ALZET). Infarct volumes were assessed by image analysis of sequential corona] brain 1 mm(3) sections stained following the 2,3,5-triphenyltetrazolium chloride histological staining technique. Results of this study provide evidence of a significant reduction of the brain lesion size, suggesting ONO-1714 as a potential neuroprotective agent in stroke patients. ONO-1714 was prepared in our laboratory following a procedure which resulted in the supply of the desired compound in an easy and excellent yield. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.05.031